(Q34449586)

2 August 2017

Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man. (English)

1 reference

2 August 2017

Boobis AR

1

1 reference

2 August 2017

Brodie MJ

2

1 reference

2 August 2017

Kahn GC

3

1 reference

2 August 2017

Toverud EL

4

1 reference

2 August 2017

Blair IA

5

1 reference

2 August 2017

Murray S

6

1 reference

2 August 2017

Davies DS

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1981

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

12

1 reference

2 August 2017

771-777

1 reference

2 August 2017

6

1 reference

Protein measurement with the Folin phenol reagent

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

The Effect of Spironolactone on Antipyrine Metabolism in Man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Metabolism of antipyrine by the epoxide-diol pathway in the rat, guinea pig and human

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

The metabolism of (ureyl-14C)tolbutamide in vitro and in vivo in man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

4,4?-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in Man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Comparison of rate of Hepatic Metabolismin vitroand Half-Life for Antipyrinein vivoin Three Species

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Multiplicity of mammalian microsomal cytochromes P-45

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene Treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

The antipyrine test in clinical pharmacology: Conceptions and misconceptions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401933

Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1981.TB01305.X

Differential induction of antipyrine metabolism by rifampicin.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1981.TB01305.X

Genetic Control of Drug Levels in Man: Antipyrine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1981.TB01305.X

Rapid gas-liquid chromatographic estimation of antipyrine in plasma

21 January 2018

1 reference

12 December 2020

Antipyrine as an in vitro probe of mixed function oxidase activity [proceeding]

1 reference

12 December 2020

Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo

1 reference

12 December 2020

An improved combined gas chromatographic mass spectrometric assay for the estimation of norphenazone in urine

1 reference

12 December 2020

Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man

1 reference

12 December 2020

Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine

1 reference

12 December 2020

Antipyrine metabolism in man

1 reference

12 December 2020

10.1111/J.1365-2125.1981.TB01305.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference